The Case for Combination Therapy as First-Line Treatment for the Type 2 Diabetic Patient

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.5, Iss.3, 2006-01, pp. : 131-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bismuth-Based First-Line Therapy for Helicobacter pylori Eradication in Type 2 Diabetes Mellitus Patients

Digestion, Vol. 82, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line Therapy

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 261-264

Karger

Access to resources Recommend Favorite

Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria

Current HIV Research, Vol. 13, Iss. 3, 2015-05 ,pp. : 184-192

Bentham Science Publishers

Access to resources Recommend Favorite

Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 71-79

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori -related peptic ulcer disease in Kashmir, India

By Shah Altaf

Indian Journal of Gastroenterology, Vol. 32, Iss. 1, 2013-01 ,pp. : 32-36

Springer Publishing Company

Access to resources Recommend Favorite